Evidence Library
Filter by drug, type, year, and open access.
Showing 1–5 of 5 results
- TIP 63: Medications for Opioid Use Disorder — SAMHSA (2021)• Drug: buprenorphine-naloxoneOpen access
- The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update — Journal of Addiction Medicine (2020)• Drug: buprenorphine-naloxoneDOIPMID
- Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial — The Lancet (2018)• Drug: buprenorphine-naloxoneOpen accessDOIPMIDPMCID
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies — BMJ (2017)• Drug: buprenorphine-naloxoneOpen accessDOIPMIDPMCID
- Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence — Cochrane Database of Systematic Reviews (2014)• Drug: buprenorphine-naloxoneOpen accessDOIPMIDPMCID